Immunological factors that affect the in vivo fate of T7 phage in the mouse.
about
Virus-Based Nanoparticles as Versatile NanomachinesPhage display as a promising approach for vaccine developmentBio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complementApplications of viral nanoparticles in medicine.Cargo Delivery into the Brain by in vivo identified Transport Peptides.Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.A3R Phage and Staphylococcus aureus Lysate Do Not Induce Neutrophil Degranulation.Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine.Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.Phages in the Human Body.Biodistribution and toxicity evaluation of sesbania mosaic virus nanoparticles in mice.Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy.Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.Metals Enhance the Killing of Bacteria by Bacteriophage in Human Blood.Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients.Immunocompatibility of Bacteriophages as Nanomedicines
P2860
Q28068538-45971284-FD44-46C4-A9C5-6351E29CB173Q28074592-908047C9-21BE-42F7-9661-7A99B0D297B3Q33771285-992CF131-73AC-437B-98DD-EEF8F855A52FQ34597583-F1763D60-43C4-4163-866F-7950403493C1Q35501007-7C2E381D-9C5A-4D36-A947-50BF1B5A449DQ35789877-E6199CBF-A420-463D-AA29-EC975DE34DDAQ36204756-71DDBB84-00C5-49B3-A8C2-28E568E2A89AQ37134047-AB340FB9-6484-4C50-9F52-639599913D91Q37428539-DC724DC3-A6A8-475C-A79F-01F3A19DE5D5Q37676099-D36AA024-C580-47AC-AE8B-10C83EE32D2BQ38122098-AF3CC1D9-5CCF-4B3F-8AC4-86B68D8C1B61Q39023156-AE67E37B-FEB4-4AB1-B8BB-5408A0667E42Q39249579-BF6E47BA-471E-4F7F-B941-3A14670B615CQ40659970-7F0DE695-5D3D-42B2-A9DC-C940C186C151Q40765081-DA670B39-AA89-4053-950D-1BDD1B5AFBE7Q41453198-0EA1E8AE-464D-4DB3-98B4-B8727C73B21AQ49297714-AF13EB40-CF15-4979-B420-4D42B6F1827FQ55373289-12085EC8-F27D-4EA0-9A7D-F83C78A0D441Q58910820-3BAEED22-FD3A-42C9-A85D-2C7D1CC6D43A
P2860
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@ast
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@en
type
label
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@ast
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@en
prefLabel
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@ast
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@en
P2093
P1476
Immunological factors that affect the in vivo fate of T7 phage in the mouse.
@en
P2093
Anand S Srivastava
Ewa Carrier
P304
P356
10.1016/J.JVIROMET.2003.09.009
P577
2004-01-01T00:00:00Z